Whitehouse Laboratories Announces Development of Container Testing Center - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Whitehouse Laboratories Announces Development of Container Testing Center



Untitled Document

Whitehouse Laboratories announced the expansion of a new laboratory dedicated to container testing. The expansion will include will a 5000 ft2 laboratory for routine container testing and a Container Closure Integrity Test (CCIT) facility. The laboratory is expected to be complete by February 1, 2014.

The laboratory will contain all instruments required to meet the new USP routine testing directives expected in 2014. In addition, the CCIT laboratory will provide method development, validation, and testing services, which include helium flow, vacuum decay, electrical conductivity, laser diffraction, and residual seal force. The facility will also include onsite capping ability and a full-service package distribution laboratory. The laboratory will be under the direction of Brian Mulhall, who has over 20 years of container and package testing experience.

Source: Whitehouse Laboratories

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here